| A promoter-level mammalian expression atlas Nature 507 (7493), 462-470, 2014 | 1712 | 2014 |
| Two distinct immunopathological profiles in autopsy lungs of COVID-19 R Nienhold, Y Ciani, VH Koelzer, A Tzankov, JD Haslbauer, T Menter, ... Nature communications 11 (1), 5086, 2020 | 250 | 2020 |
| Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer D Walerych, K Lisek, R Sommaggio, S Piazza, Y Ciani, E Dalla, ... Nature cell biology 18 (8), 897-909, 2016 | 242 | 2016 |
| HMGA1 promotes metastatic processes in basal-like breast cancer regulating EMT and stemness S Pegoraro, G Ros, S Piazza, R Sommaggio, Y Ciani, A Rosato, R Sgarra, ... Oncotarget 4 (8), 1293, 2013 | 155 | 2013 |
| Differential roles of epigenetic changes and Foxp3 expression in regulatory T cell-specific transcriptional regulation H Morikawa, N Ohkura, A Vandenbon, M Itoh, S Nagao-Sato, H Kawaji, ... Proceedings of the National Academy of Sciences 111 (14), 5289-5294, 2014 | 143 | 2014 |
| Functional annotation of human long noncoding RNAs via molecular phenotyping JA Ramilowski, CW Yip, S Agrawal, JC Chang, Y Ciani, IV Kulakovskiy, ... Genome research 30 (7), 1060-1072, 2020 | 139 | 2020 |
| miR-155 drives telomere fragility in human breast cancer by targeting TRF1 R Dinami, C Ercolani, E Petti, S Piazza, Y Ciani, R Sestito, A Sacconi, ... Cancer research 74 (15), 4145-4156, 2014 | 130 | 2014 |
| A gene expression signature of retinoblastoma loss-of-function is a predictive biomarker of resistance to palbociclib in breast cancer cell lines and is prognostic in patients … L Malorni, S Piazza, Y Ciani, C Guarducci, M Bonechi, C Biagioni, ... Oncotarget 7 (42), 68012, 2016 | 126 | 2016 |
| A covalent PIN1 inhibitor selectively targets cancer cells by a dual mechanism of action E Campaner, A Rustighi, A Zannini, A Cristiani, S Piazza, Y Ciani, O Kalid, ... Nature communications 8 (1), 15772, 2017 | 124 | 2017 |
| Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism G Antoniali, F Serra, L Lirussi, M Tanaka, C D’Ambrosio, S Zhang, ... Nature Communications 8 (1), 797, 2017 | 105 | 2017 |
| Mutant p53 tunes the NRF2-dependent antioxidant response to support survival of cancer cells K Lisek, E Campaner, Y Ciani, D Walerych, G Del Sal Oncotarget 9 (29), 20508, 2018 | 104 | 2018 |
| A novel HMGA1-CCNE2-YAP axis regulates breast cancer aggressiveness S Pegoraro, G Ros, Y Ciani, R Sgarra, S Piazza, G Manfioletti Oncotarget 6 (22), 19087, 2015 | 76 | 2015 |
| Translating proteomic into functional data: an high mobility group A1 (HMGA1) proteomic signature has prognostic value in breast cancer E Maurizio, JR Wiśniewski, Y Ciani, A Amato, L Arnoldo, C Penzo, ... Molecular & Cellular Proteomics 15 (1), 109-123, 2016 | 70 | 2016 |
| HMGA1 promotes breast cancer angiogenesis supporting the stability, nuclear localization and transcriptional activity of FOXM1 R Zanin, S Pegoraro, G Ros, Y Ciani, S Piazza, F Bossi, R Bulla, ... Journal of Experimental & Clinical Cancer Research 38, 1-23, 2019 | 65 | 2019 |
| GTSE1 is a microtubule plus-end tracking protein that regulates EB1-dependent cell migration M Scolz, PO Widlund, S Piazza, DR Bublik, S Reber, LY Peche, Y Ciani, ... PLoS one 7 (12), e51259, 2012 | 65 | 2012 |
| Circulating RNAs in prostate cancer patients V Mugoni, Y Ciani, C Nardella, F Demichelis Cancer letters 524, 57-69, 2022 | 53 | 2022 |
| PIN1 in breast development and cancer: a clinical perspective A Rustighi, A Zannini, E Campaner, Y Ciani, S Piazza, G Del Sal Cell Death & Differentiation 24 (2), 200-211, 2017 | 53 | 2017 |
| OCT4 controls mitotic stability and inactivates the RB tumor suppressor pathway to enhance ovarian cancer aggressiveness E Comisso, M Scarola, M Rosso, S Piazza, S Marzinotto, Y Ciani, ... Oncogene 36 (30), 4253-4266, 2017 | 50 | 2017 |
| Epigenetic silencing of miR-296 and miR-512 ensures hTERT dependent apoptosis protection and telomere maintenance in basal-type breast cancer cells R Dinami, V Buemi, R Sestito, A Zappone, Y Ciani, M Mano, E Petti, ... Oncotarget 8 (56), 95674, 2017 | 41 | 2017 |
| An NF-κB signature predicts low-grade glioma prognosis: A precision medicine approach based on patient-derived stem cells T Ius, Y Ciani, ME Ruaro, M Isola, M Sorrentino, M Bulfoni, V Candotti, ... Neuro-oncology 20 (6), 776-787, 2018 | 37 | 2018 |
Silvano PiazzaInternational Centre for Genetic Engineering and Biotechnology在 icgeb.org 的电子邮件经过验证
